The AI Trade Isn't Dead (Here Are 5 Stocks to Buy) — Transcript
Full transcript
- 0:00The AI data center trade is
- 0:01transitioning, not ending. The
- 0:04transition is painful and it may not be
- 0:06over. Maybe more shoes to drop if you
- 0:09well, more legs lower if you well, but
- 0:12eventually we are going to bottom and
- 0:13when we do bottom, I think it's going to
- 0:15be a massive rebound rally on the other
- 0:17side as the market adjusts to the new
- 0:18normal of stable but still high capital
- 0:22spending plans from the hyperscalers.
- 0:24>> Hello and welcome to Bang Exponential.
- 0:26Today we're going to be covering our
- 0:27five stocks of the week. Uh so Luke, we
- 0:29had a almost broad spectrum of stocks
- 0:32here this week. Let's start off with
- 0:34Cloudflare, NET.
- 0:38>> Yeah, bro. So I think that the the setup
- 0:40for the market has dramatically changed
- 0:42over the last week. Um the price action
- 0:45has been very violent and some major
- 0:48technical levels are are breaking and
- 0:50fundamental conditions have changed too.
- 0:53And so I think in response to that, you
- 0:56know, our
- 0:57thesis has been AI with AI, which has
- 1:01been expressed through being all in with
- 1:04the AI supply chain stocks, the uh
- 1:07nebulas of the world, the Marvels of the
- 1:09world, the Broadcoms of the world, the
- 1:10AMDs of the world, the Nvidias of the
- 1:12world, the recent networks of the world,
- 1:13etc etc.
- 1:15That trade is under significant
- 1:17pressure, has been under significant
- 1:18pressure and it looks like the pressure
- 1:20there could persist for a little while
- 1:23longer. I don't think the trade is dead
- 1:24by any means. We'll talk about that in
- 1:25our macro podcast, but I do think that
- 1:28that there is more pressure there uh in
- 1:31the short term and that things could get
- 1:33worse before they get better. So this
- 1:35episode I want to focus on stocks that I
- 1:37think can
- 1:39weather
- 1:41that storm really well. There are parts
- 1:43of the market that despite the broader
- 1:46weakness and despite the specific
- 1:47weakness in the AI trade have done
- 1:50pretty well in the last month, in the
- 1:53last three months, in the last six
- 1:55months. And these are the stocks that I
- 1:58think investors can shelter in during
- 2:01this very turbulent period for the AI
- 2:04trade. And so one of them is Cloudflare.
- 2:08Now Cloudflare obviously that's the
- 2:10cybersecurity play. We've talked about
- 2:12cyber before when we had JR on the
- 2:13podcast. We didn't talk about Cloudflare
- 2:16specifically, but that's probably my
- 2:18favorite name in the entire cyberspace
- 2:20cuz they're basically the the doorman
- 2:23for the internet. So that anytime
- 2:26there's traffic on the internet internet
- 2:27or somebody wants to go on a website,
- 2:29they're sort of the doorman allowing
- 2:31traffic into that website.
- 2:34That's really important in the era of
- 2:36agentic AI because internet traffic is
- 2:41one going to grow dramatically. We've
- 2:44already seen that because it's not users
- 2:47anymore, it's agents and every user can
- 2:50have 10 20 30 40 50 hundreds of agents
- 2:54that are constantly running throughout
- 2:56the internet. So internet traffic grows
- 2:58exponentially in the era of agentic AI.
- 3:01And two, these agents have different
- 3:04behaviors than humans. And they have
- 3:08different intentions and is it a rogue
- 3:11agent? Is it a planned agent? What
- 3:13what's the intention behind the action
- 3:14that it's doing? So the sort of
- 3:16behavioral analysis of the doorman also
- 3:20has to fundamentally change. And so I
- 3:22think those are two massive tailwinds
- 3:25for company that protects websites, that
- 3:28protects the internet if you will. And
- 3:31that's Cloudflare. Cloudflare is the
- 3:33king of this space. They are the big
- 3:35dog. They are a massive growth company
- 3:38and I really like the setup here because
- 3:40they just reported earnings.
- 3:42Earnings were fantastic. This is a stock
- 3:44that you can see here in the chart. It
- 3:46pulled back pretty dramatically, right?
- 3:47This is a stock that topped out right
- 3:49around 350 uh in late September, early
- 3:51October and then it crashed all the way
- 3:53to 250 right at the 200 day and then
- 3:54look at this V-shaped recovery. Like
- 3:56that is exactly what you want to see.
- 3:58One of our favorite setups is long-term
- 4:01winner and a short-term pullback that is
- 4:03now U-turning. It's exactly what you
- 4:05have here. Long-term winner, short-term
- 4:07pullback, now U-turning at the most
- 4:09important technical support level. And
- 4:11better yet, it's bouncing because of a
- 4:14strong fundamental catalyst with their
- 4:16recent earnings report last week that
- 4:18was absolutely fantastic.
- 4:21The caveat here is you're paying a crap
- 4:23ton for the stock, 163 times forward
- 4:26earnings, 106 times forward EBITDA. But
- 4:29as you can see on a two-year basis,
- 4:30that's actually below average on the PE
- 4:32multiple, a little bit below average on
- 4:34the EBITDA multiple. So I really don't
- 4:36think this one is like the valuation
- 4:37should be that much of a headwind. I
- 4:39really like Cloudflare here. I like the
- 4:41cyberspace. We talked about that
- 4:43previously, but we missed my favorite
- 4:44stock and that's Cloudflare. I think the
- 4:46entry point here on a bounce off the 200
- 4:48day is really attractive.
- 4:51>> Awesome. Yeah, I mean the the the
- 4:52valuations are almost the MO for these
- 4:55cybersecurity stocks. So I have about
- 4:56two kind of follow-ups here, Luke. One
- 4:59is almost tangential. So you mentioned
- 5:01the AI agents thing. So notably, I think
- 5:04Jamie Diamond
- 5:05banned the use of AI agents in online
- 5:08banking. Do you think that would be more
- 5:10pervasive in, you know, the broader
- 5:12market where companies are disallowing
- 5:15the use of agents?
- 5:16>> No, I think the use of agents is going
- 5:18to it's going to be enormous. I don't
- 5:19think these are like kind of one-off
- 5:21cases where it gets banned here, banned
- 5:22there. And where it gets banned, it's
- 5:24for the temporary pause. It's more of
- 5:25like let's think about how we're going
- 5:27to use them and then let's use them
- 5:28responsibly. Kind of like what's going
- 5:29on with the data center
- 5:31trade, right? It's not an outright
- 5:34stalling in capital expenditures for
- 5:37building new data centers, but it's now
- 5:38like, okay, let's sit back and think
- 5:40about how we can do this more
- 5:41responsibly.
- 5:42That's sort of how I viewed the agent
- 5:44trade, too. So I don't think the agent
- 5:46the growth of agents is a trend that's
- 5:48going to stop anytime soon.
- 5:50I think there may be pauses here and
- 5:51there, but the overall trend will be
- 5:52exponential growth in agentic traffic on
- 5:55the internet, and that is a exponential
- 5:57tailwind for a stock like Cloudflare.
- 6:00>> Of course, agreed. And then second, this
- 6:02is kind of a broader question for all of
- 6:04these stocks. So to clarify, this isn't
- 6:06a rotation out of our, you know, core AI
- 6:09trades. This is more of a broadening of
- 6:10our portfolio to kind of hedge it. Is
- 6:13that Is that right?
- 6:14>> Yeah, I [clears throat] would I would
- 6:15say that
- 6:17yes and no. We're in a very confusing
- 6:19period for the markets. We'll talk about
- 6:21it a lot more in the macro podcast
- 6:23coming up, but
- 6:24we're in a very confusing period where
- 6:27things could go either way. Um the
- 6:32the demand for AI is still amazing and
- 6:36sensational.
- 6:37And if that were the only thing that
- 6:40mattered, then the trade is very much
- 6:42alive and well. But it's not the only
- 6:44thing that matters. That Washington has
- 6:46entered the conversation. Wall Street
- 6:48has entered the conversation. Supply
- 6:50chain shortages have entered the
- 6:52conversation. And so these three
- 6:54non-demand related factors can put
- 6:57significant downward pressure on the
- 7:00data center trade, the AI data center
- 7:02trade in the short term.
- 7:04I I don't think it says anything about
- 7:05the 12 to 24 to 36 month outlook on
- 7:09these stocks, but it does say a lot
- 7:11about the uncertainty over the next
- 7:12three to six months. And I think it's
- 7:14very likely
- 7:16that we do see capital expenditures from
- 7:19the hyperscalers come in lower than
- 7:21expected for 2027 and 2028, lower than
- 7:25planned. And so if that happens, and for
- 7:28our previous podcast was, you got to
- 7:30fundamentally ask yourself the question,
- 7:31will the hyperscalers stop spending?
- 7:34Will they reduce their spending? If no,
- 7:37stay bullish. If yes, get cautious. In
- 7:40the last week, enough factors have
- 7:42changed for me. When I ask that question
- 7:45now, I have to say
- 7:47it won't slow,
- 7:50but it's probably not going to grow a
- 7:51whole bunch. And the problem with that
- 7:53is that the estimates price in
- 7:55hyperscaler CapEx growth into like 2030.
- 8:00And those estimates are probably wrong.
- 8:02We probably stay We'd probably get a big
- 8:03jump in 27 that's smaller than expected.
- 8:06And then 28, 29, 30 are probably stable
- 8:08levels of spending, which means those
- 8:10CAPEX estimates have to come down. And
- 8:12if the CAPEX estimates come down, that
- 8:14means the receiving end has to come down
- 8:16as well, the EPS estimates for the
- 8:18entire AI supply chain. So I think we're
- 8:20kind of due for downward revisions in a
- 8:22lot of those estimates, and that can put
- 8:24pressure on the trade in the short term.
- 8:26But we're going to find a steady state
- 8:28on the other end of that transition
- 8:29where it's like,
- 8:31okay, these earnings are still big. Now
- 8:33they're at a base. Now they can grow
- 8:35sustainably and the trade rebounds like
- 8:36crazy. I think we're going to get one of
- 8:37the best buying opportunities uh in the
- 8:39last 25 years in tech stocks in the next
- 8:43three months, but I don't think it's
- 8:44right now. So that's why we're focusing
- 8:46on sort of okay, the AI trade is, you
- 8:49know, put on hold, put on pause. It's in
- 8:50timeout. It's in the corner, that core
- 8:52data center trade. These are stocks that
- 8:54you can play in the meantime, in my
- 8:56opinion, while that data center trade is
- 8:58kind of in in the timeout zone.
- 9:01>> Definitely. And yeah, of course, we're
- 9:02going to dig into that more in the macro
- 9:04episode. Uh but next up, let's uh talk
- 9:06about JFrog. So they reported 31%
- 9:09revenue growth and their cloud revenue
- 9:11increased over 60%.
- 9:13>> Yeah, JFrog is a stud. JFrog is the
- 9:16exact type of stock you want to own in
- 9:17this environment because it's the type
- 9:19of stock that kind of like Cloudflare,
- 9:21but even more uh
- 9:23emphatically, has a ton of exposure to
- 9:26growth in AI adoption, but not a ton of
- 9:31exposure to AI CAPEX. So the data center
- 9:35build out can slow or stall or whatever
- 9:37word you want to use, and it won't
- 9:40impact JFrog because like I said, that
- 9:43slowdown is not demand driven. It's
- 9:45Washington driven, Wall Street driven,
- 9:46supply chain driven. Demand is still
- 9:49there. So if you have a non-demand
- 9:51driven slowdown, yes, that's going to
- 9:52hurt the supply chain companies, but
- 9:54it's not going to hurt the application
- 9:55layer. And JFrog is at that application
- 9:58layer. Really like
- 10:00every line the the
- 10:01400-ft bolt thesis here is that every
- 10:04line of code that an AI writes becomes a
- 10:09software file that has to be stored and
- 10:13secured and tracked. And that is
- 10:16JayFrog's whole business. They kind of
- 10:17create that software, if you will, that
- 10:21stores, secures, and tracks essentially
- 10:23every line of AI software code. So the
- 10:25idea is that more AI code, more demand
- 10:29for JayFrog, higher revenues, higher
- 10:31profits. And that's exactly what you saw
- 10:33in their in their earnings report. If
- 10:34you kind of pull up the numbers here, I
- 10:36mean, you you kind of named a few, but
- 10:38yeah, I mean, revenues are up 31%. Cloud
- 10:41revenue is 60% of sales. Contracted
- 10:44future revenue there, their RPO or
- 10:46remaining performance obligations up
- 10:4760%. Uh net retention of 124%, which is
- 10:51ridiculous. Gross retention of 97%.
- 10:54Uh they grew their number of big ticket
- 10:57customers, $1 million plus customers uh
- 10:59by 60% in the quarter, 58%. Uh the guide
- 11:03was way above expectations on both
- 11:05revenue and EPS. I mean, it was just
- 11:07like it was a fantastic report and the
- 11:08stock obviously soared like crazy. And
- 11:11if you look at the chart, like I said,
- 11:12we want to look for stocks that
- 11:15have been working in the chaos. Frog is
- 11:17a stock that has been working in the
- 11:19chaos. Look at that. It just it's
- 11:20sprinting to new highs. It was the stock
- 11:23that had this consolidation for a bit,
- 11:24dropped to the 200-day moving average,
- 11:26and is now blasting higher to new highs.
- 11:28That's that's fantastic to see. RSI is
- 11:31not overbought. It's right around just
- 11:33below 60. You got a bullish MACD
- 11:34crossover, you got great momentum. Uh
- 11:36the growth profile here is absolutely uh
- 11:40amazing when you look at uh the out-year
- 11:42estimates. And again, these estimates
- 11:44feel stable to me because it's tied to
- 11:46AI adoption, not AI CapEx. So you got
- 11:49basically compounded 20% revenue growth
- 11:51on the top line to an 80% plus gross
- 11:53margin business with stable EBITDA
- 11:55margins. You have 20% plus on the bottom
- 11:57line, and you're not paying all that
- 11:59much for it here. When you look at the
- 12:01valuation for that,
- 12:03you're only paying I mean, 81 times
- 12:05sounds like a lot, but on EBITDA you're
- 12:07paying 68.5 times. You're on the upper
- 12:10end of the valuation range, but it's
- 12:11really not super expensive for a high
- 12:13margin, high cash flow, high growth
- 12:17company tied to the biggest tailwind in
- 12:20the economy right now. So Jfrog to me is
- 12:22the exact type of stock that you want to
- 12:24own at this moment. I really like this
- 12:26one.
- 12:28>> Excellent.
- 12:28>> Yeah, love that.
- 12:29>> All right, so next up uh we're going
- 12:31into the biotech sector uh
- 12:33>> Mhm.
- 12:34>> relatively seasonal sector. Uh first up
- 12:36is Adaptive Biotechnologies, ADPT.
- 12:39>> Right. Right. So the the big picture
- 12:41both these is so biotech's been having a
- 12:42moment. Biotech stocks have been doing
- 12:44really well. Healthcare stocks have been
- 12:46doing really well. Again, the continuing
- 12:48this theme of looking for stocks that
- 12:50have done well in the chaos. Biotech and
- 12:52healthcare are the two sectors that have
- 12:53done really really well in the chaos.
- 12:55Now what Adaptive does is they own the
- 12:57leading tests for spotting the last
- 13:00traces of blood cancer after treatment.
- 13:02Uh medical guidelines are moving toward
- 13:04testing patients more often uh which
- 13:07should give the company years of steady
- 13:10profitable growth with no link again to
- 13:13this AI CapEx slowdown. So it's a
- 13:16company that has some AI driven
- 13:18tailwinds. They're using AI with a lot
- 13:20of that testing. They have an AI
- 13:21subdivision. Um the growth is is strong
- 13:25and it's independent of the capital
- 13:28spending trends uh or capital spending
- 13:30plans of the hyperscalers. Um their
- 13:33their main product is this this Clono
- 13:36SEQ they call it, which is a blood or
- 13:38bone marrow test for cancers like
- 13:39multiple myeloma, leukemia, and
- 13:42lymphoma. That
- 13:44test is growing very very very quickly.
- 13:47If we kind of pull up the numbers on
- 13:49their recent results here um
- 13:54yeah, I mean the the the number of those
- 13:56Clono SEQ tests was 39,587
- 14:00which is up 60 46%
- 14:03uh year over year. Massive growth there.
- 14:06And if you look at the growth that it's
- 14:07supposed to persist, look at the growth
- 14:09profile for ADPT
- 14:13going out to 2029. Let's pull up those
- 14:16estimates again. So, big growth. 22, 24,
- 14:2016, 18, call it compounded 20. Gross
- 14:23margin 74 up to 77. The most attractive
- 14:27thing about this is we're going to
- 14:28finish the year at 3% EBITDA margins.
- 14:30When you have a 20% plus top line grower
- 14:33with 70% plus gross margins that is only
- 14:36at 3% EBITDA margins, that either means
- 14:38one, the company is very poorly run, or
- 14:41two, there's a lot of room for operating
- 14:43leverage over the next several years.
- 14:45And that's exactly what I'm expecting
- 14:46here. EBITDA margins running from 3
- 14:48million or 3% rather 9 million to 29% in
- 14:52183 million dollars. This is one of the
- 14:54biggest EBITDA growth profiles in the
- 14:56market right now. Very attractive. Now
- 14:59the valuation is a little steep, but I
- 15:02don't think it's steep enough
- 15:03considering that growth profile. 108.4
- 15:06times EBITDA, but if you look over here
- 15:08and you see EBITDA gets up to 200
- 15:09million dollars, okay. 200 million
- 15:11dollars, a stock like this can trade at
- 15:13easily, you know, 40 50 times the
- 15:15earnings or EBITDA. 200 on 50 is 10
- 15:18billion. That's a double in like two or
- 15:20three years. So, this is a stock that I
- 15:22think the valuation has room to expand.
- 15:24I also think those out year estimates
- 15:27excuse [clears throat] me, move higher.
- 15:28And then you look at the chart
- 15:30and the chart again is just really
- 15:31attractive. What has been working? Look
- 15:33at this chart. This has been working.
- 15:35Great uptrend on the stock. Came into
- 15:37[snorts] its 100 day, bounced back into
- 15:39its 100 day, bounced, about to make a
- 15:40new high. Actually is at a new high.
- 15:43Maximum drawdown right now is 0 percent,
- 15:45so it did make a new high today. RSI is
- 15:48not overbought. MACD looks good.
- 15:50Momentum looks good. This is a winning
- 15:52stock. It's got upside. I think this is
- 15:55a a a good play amidst the recent chaos.
- 15:59>> Yeah, that's that's awesome. A blood
- 16:00test that actually works. Um so with
- 16:02>> actually works. There you go.
- 16:05>> So with uh with their MN their minimal
- 16:07residue residual disease testing, it's
- 16:10not currently routine. If it does become
- 16:13a routine part of cancer treatment, do
- 16:14we have an idea of what that TAM is, how
- 16:17much growth we can expect from that.
- 16:19>> that's why I think these estimates are
- 16:21low, right? I mean, I think you're the
- 16:22MRD business is
- 16:25working, but it's not
- 16:28I mean, it's the main engine of growth,
- 16:29but it could be a lot bigger than what
- 16:31it is today. And if that starts to
- 16:33really kick in, I don't think his
- 16:34estimates price that in. And so like I
- 16:36said, I use 200 million EBITDA. That's
- 16:38kind of like an exit goal for 2030. We
- 16:40could probably get to 300 or 400
- 16:42million. We probably double that. And
- 16:43then all of a sudden, you know, the
- 16:44valuation here can get really really
- 16:46big. So
- 16:47this is a stock that even on
- 16:48conservative estimates doesn't look
- 16:50overvalued right now. And if you get,
- 16:53you know, more aggressive estimates
- 16:54baked in there, it's a stock that could
- 16:56really fly. So I I really like this one.
- 16:58It's been on an uptrend for a while,
- 17:00right? If you look at the long-term
- 17:01chart, it really kind of bottomed in
- 17:02late 24 early 24 at around, you know,
- 17:05two bucks and change and now it's 30. So
- 17:0715 bagger if you want to look at it from
- 17:09that perspective. I just think this
- 17:11uptrend has a lot of runway. So this is
- 17:13a good company and it's a good stock.
- 17:15And so I think this is a good time to to
- 17:18play defense, if you will, with it.
- 17:21>> Awesome. Okay. So moving on to another
- 17:24company pretty similar or similar
- 17:26enough, Tempest AI, which is a true AI
- 17:29healthcare platform.
- 17:30>> Right. Yep. Yeah. I mean, so again,
- 17:32biotech healthcare, it's been working.
- 17:34So let's go with what's working. Tempest
- 17:36has been one of our favorite companies
- 17:38at the AI application layer for a very
- 17:40long time. It's in a very volatile
- 17:41stock, but it's starting to really have
- 17:43a moment in the market. What the
- 17:46company's done is they've essentially
- 17:47they're pioneering personalized AI
- 17:49medicine, which is this whole idea that
- 17:52with AI, we can personalize healthcare
- 17:54treatments to you
- 17:56and not just a general treatment, but a
- 17:58personalized treatment to you. And
- 18:00obviously the the fuel of that and what
- 18:04determines how
- 18:06the efficacy of a personalized AI
- 18:08healthcare treatment plan is going to be
- 18:11the underlying data. And Tempest has
- 18:14built one of the largest collections of
- 18:16patient data in the entire medical
- 18:19industry. And they are leveraging that
- 18:21data to create very robust AI algorithms
- 18:23and then partnering with very large
- 18:25healthcare firms to pioneer personalized
- 18:28AI healthcare treatments. And so this is
- 18:31a company that again I think is they're
- 18:32in the early innings of a massive
- 18:34massive growth burst. Uh they just
- 18:37reported earnings what was like a week
- 18:38or two ago. Really good numbers. We can
- 18:41pull those up here.
- 18:43Revenue was up 23% year over year. Uh
- 18:46their cancer test volume was up 32%
- 18:48their data and AI revenue was up 33%
- 18:52adjusted EBITDA jumped from 1.5 million
- 18:54to 25.6
- 18:57uh million. Really just absolutely
- 19:00crushing it. Uh
- 19:02bookings guidance was strong. Revenue
- 19:04guidance was strong.
- 19:05You look at the growth profile here. 26%
- 19:08this year on the top line 24 21 2017
- 19:12no AI CAPEX exposure here. Those
- 19:16estimates can probably drift higher.
- 19:19Very similar situation as you have with
- 19:21ADT ADPT where you have a high gross
- 19:23margin business that one was 70% plus
- 19:25this one is 65% plus inching towards 70
- 19:28trading at a low single digit uh EBITDA
- 19:31margin
- 19:32EBITDA margin right now 4%. So that can
- 19:35you know through operating leverage get
- 19:37from 4 to 24 and EBITDA goes from 65 to
- 19:40800 million. And I think actually I
- 19:42think 2030 EBITDA could look more like a
- 19:44billion.
- 19:45And again stock like this high growth
- 19:47high margin high cash flow biotech
- 19:49company uh healthcare technology company
- 19:52whatever you want to call it uh can
- 19:54trade at you know 40x earnings or 40x
- 19:56EBITDA pretty easily. So if this gets to
- 19:58a billy
- 19:59by 2030 you put 40 on it that's 40 billy
- 20:02and we're at 15 billion now. So that's a
- 20:04lot of upside in the next three years.
- 20:06And so I think this one has a lot of
- 20:08fundamental driven upside. And then when
- 20:10you look at the chart it's really
- 20:11starting to flash some breakout signals
- 20:13to me. You know Tempest AI like I said
- 20:16it's been a volatile stock. It's kind of
- 20:18gone it's yo-yoed quite a bit but right
- 20:20now it's yo-yoing up. And I think that
- 20:22yo-yo up has has runway. You can see
- 20:24again I kind of want to just show the
- 20:25volatility in this name.
- 20:27Uh it's been very volatile for a while.
- 20:30Had that big run in 25 and then gave it
- 20:33all back pretty much and now we're
- 20:34having another big run. The fact that
- 20:37we're breaking above there's this big
- 20:38peak right here right around what is
- 20:40that? 72 we crushed through that. Had
- 20:43this big peak around 77 crushed through
- 20:45that. So the fact that we're crushing
- 20:47these previous peaks tells me we're at
- 20:49least getting to 90 you know this high
- 20:51from February and then some highs back
- 20:53here in in September. We're going to at
- 20:55least get the 90 on this one and I think
- 20:56we're actually getting the cycle turn
- 20:59you know the 50 above the 100 above the
- 21:01200 200 slope now turning higher. This
- 21:04looks like a pretty big turn and so I
- 21:06think we make a push for all time highs
- 21:08and that all time high was uh October
- 21:102025 around 103 I think we get above
- 21:13that to 110. So I think in the short
- 21:14term we got pretty good upside here and
- 21:16the long term fundamentals also look
- 21:17great so Tempest stock has my stamp of
- 21:20approval in this current market.
- 21:22>> [snorts]
- 21:22>> That's awesome. Is there a conflict of
- 21:24interest between Tempest and ADPT like
- 21:27uh with its you know kind of data moat?
- 21:29Would it essentially eat ADPT's lunch in
- 21:31the the future if its models keep
- 21:33growing?
- 21:34>> Conflict of interest I I mean I don't
- 21:37know if it's conflict of interest. They
- 21:38they are they are competitive in a very
- 21:41growing market but it's kind of like AMD
- 21:42and Nvidia. Uh it's kind of like a
- 21:45recent networks and momentum it's kind
- 21:47of like there's just there's a lot of
- 21:49growth in this area uh of the biotech
- 21:52world you know using AI to improve
- 21:54clinical outcomes and I do think
- 21:57healthcare outcomes and patient outcomes
- 21:59and I do think the Tempest and ADPT and
- 22:01then some others out there can succeed
- 22:03side by side. They're not going to be
- 22:05rubbing elbows. There's a lot of green
- 22:06space in this patch a lot of opens uh
- 22:08space in this past year and so I don't
- 22:10think they're going to be rubbing elbows
- 22:11for a very very long time.
- 22:14>> Roger that. Okay uh last but certainly
- 22:16not least the healthcare giant Eli Lily
- 22:20uh LLY.
- 22:22>> Yeah I mean Lily so the the growth
- 22:25engine of the market in the last three
- 22:28years has been two really.
- 22:31One, AI, and then number two by a wide
- 22:34margin, you know, big distance, but
- 22:36there was a number two and that was
- 22:37GLPs, right? That was the weight loss
- 22:39stuff.
- 22:39>> Of course.
- 22:40>> And these guys are just absolutely
- 22:42crushing it there. I mean Mounjaro,
- 22:45Zepbound, these GLP-1 style drugs are
- 22:51all the rage. They're moving into pill
- 22:53form. Um the uh what do they call it?
- 22:56Foundeo, right? Foundeo is a daily
- 22:58weight loss pill they just launched. Uh
- 23:00and I think with that the growth runway,
- 23:03everybody was doubting the growth runway
- 23:05for the GLP ones, right? Everyone's
- 23:06like, okay, everyone got the shot, now
- 23:07what? Well, the growth runway extends
- 23:09dramatically with the pill. There are so
- 23:11many people out there that just will not
- 23:12take a shot, but you make a weight loss
- 23:15an effective weight loss pill and all of
- 23:17a sudden you increase the market by a
- 23:20dramatic amount. And so I think there's
- 23:22just really big growth here yet to come
- 23:25that is not priced into the stock
- 23:26because of the runway extension of the
- 23:28pill. Um Eli Lilly, you look at the
- 23:31growth profile. See, here's here's the
- 23:33thing I like about the stock. You have
- 23:35this dramatic slowdown priced in.
- 23:38Revenue's up 40% this year and then 16,
- 23:4012, 9, 7. That's a massive deceleration
- 23:44when this was a 45, 46, 40% growth
- 23:47company. Now you're going to get into
- 23:49mid teens all the way down to single
- 23:50digits? I don't think so. I think the
- 23:52pill keeps us above 15 if not above 20
- 23:56for the next two to three years. So
- 23:57these estimates got to move higher. They
- 24:00will move higher, which means the margin
- 24:02estimates are going to move higher
- 24:04because look at this. You're at 46%
- 24:05EBITDA today going up to 57. Maybe
- 24:08you're 46 to 67. So all of a sudden you
- 24:11get a you know, a 20% uplift on 2030
- 24:14revenues and you add 10 points of margin
- 24:16expansion, you get a 30 40% uplift on
- 24:19EBITDA estimates. And so I think there's
- 24:20a huge uplift to come on those EBITDA
- 24:23estimates. And when you look at the
- 24:24valuation, it's just again, it's not
- 24:26priced for accelerating growth not
- 24:29accelerating growth, but for stable and
- 24:31high growth. You look at that. I mean,
- 24:3229 times forward earnings is essentially
- 24:35a five year low. 24 times forward P/E is
- 24:38essentially a five year low. So we're
- 24:41trading it near five year low valuations
- 24:43on the assumption that growth is going
- 24:44to slow because GLP 1s have run their
- 24:46course, and I just don't think they
- 24:48have. I think that that pill is going to
- 24:50really extend the market and the sales
- 24:53runway here
- 24:54by a lot more than what the street is
- 24:55expecting and pricing in. And the stock,
- 24:57again, what has been working, oh, hey,
- 25:00look, this has been working.
- 25:02Really strong. 1,400 here, boom,
- 25:05bursting right through it, setting new
- 25:06highs.
- 25:07Things look good here. So I think this
- 25:09is a great stock and it's a great
- 25:10company. I think it's a great stock to
- 25:12hide in or play defense with amidst the
- 25:15recent market turmoil.
- 25:17>> Yeah, excellent.
- 25:19So with
- 25:21Eli Lily, the GLP essentially made it a
- 25:23a trillion dollar company.
- 25:26Do we have a fear of GLP 1s running
- 25:29their course? I know you mentioned that
- 25:30just a just a moment ago, but is there a
- 25:33concern of that in the future once maybe
- 25:35the market is saturated with them?
- 25:38>> Yeah.
- 25:40But I think we're years away from that.
- 25:42Again, I mean, let just put it here. The
- 25:44the estimates price in saturation
- 25:47happening too soon.
- 25:49So if we push out that saturation point
- 25:51because the pill outperforms, which I
- 25:53think it will, then estimates move
- 25:55higher on a low valuation and the stock
- 25:57works. Like I think it's it's that
- 25:59simple. So this fear of like when it
- 26:01becomes saturated, like yeah, we'll deal
- 26:03with that when we get close to that. But
- 26:05I don't think we're close to that.
- 26:08>> Excellent. Okay.
- 26:10Um
- 26:11I guess my question here is we we we
- 26:12touched on, you know, two different
- 26:14sectors really. So which which of these
- 26:16stocks do you think offers kind of the
- 26:18best risk adjusted return over the next
- 26:20three to five years? Are we are we
- 26:21looking at the the
- 26:23the AI software layer or the healthcare
- 26:25layer?
- 26:27>> Uh
- 26:29if you're talking about the next
- 26:31Again, it depends on on time frame.
- 26:33These stocks I'm highlighting as I think
- 26:36great stocks for the next 3 to 6 months.
- 26:40I think there's long-term
- 26:42growth potential here too. But I think
- 26:44in the next 3 to 6 months, these stocks
- 26:46outperform your AI data center stocks.
- 26:49Then I think in the next 3 to 5 years,
- 26:51the AI data center stocks actually kick
- 26:53these stocks ass. Like that's that's
- 26:55what I really believe because I think
- 26:57the trade, the AI data center trade is
- 27:00transitioning, not ending. The
- 27:02transition is painful and it may not be
- 27:05over. Maybe more shoes to drop if you
- 27:07will, more legs lower if you will. But
- 27:10eventually we are going to bottom and
- 27:12when we do bottom, I think it's going to
- 27:14be a massive rebound rally on the other
- 27:15side as the market adjusts to the new
- 27:17normal of stable but still high capital
- 27:21spending plans from the hyperscalers and
- 27:23stable but still high EPS estimates
- 27:25across the AI supply chain and then
- 27:27boom, we rebound like crazy. So I think
- 27:30in a 3 to 5 year window, data center
- 27:32stocks and a 3 to 6 month window, the
- 27:35application layer is starting to look
- 27:37really good. Healthcare looks really
- 27:39good. Biotech looks really good. I'm not
- 27:41going to go and chase the consumer
- 27:42staples trading at 30 times earnings for
- 27:442% growth. That makes no sense. There
- 27:46are a lot out there right now.
- 27:50I wouldn't chase that. I wouldn't play
- 27:51defense there. I would still play
- 27:52offense but I would play offense away
- 27:55from the the core data center trade
- 27:58until that really starts to stabilize.
- 28:01>> Okay. I think that's a great place to
- 28:03wrap the episode. As always, appreciate
- 28:04the insight, Luke. And we'd like to
- 28:06thank you for tuning in as well. Please
- 28:08make sure to like, comment and subscribe
- 28:10so we can keep the channel going and
- 28:11flowing. That's being exponential.
- 28:14Signing off.
- 28:19>> [music]
About this transcript
This page contains the full transcript of The AI Trade Isn't Dead (Here Are 5 Stocks to Buy) by Being Exponential with Luke Lango, generated from the public captions YouTube serves with the video. The transcript has 5,224 words across 773 segments, with the original timestamps preserved so you can click any line to jump to that moment in the embedded player.
What you can do with it
Use the transcript to take notes, quote the speaker, build a study guide, generate a summary with ChatGPT or Claude via the YouTube Summary tool, or export it as a timed subtitle file with YouTube to SRT. You can also re-open it in the transcriber to choose a caption track available on the video.
Free YouTube transcript tool
YouTube2Text is a free YouTube transcript generator — no signup, no daily limit. Paste any YouTube link and get the full transcript instantly, with timestamps, click-to-jump, caption language selection, AI prompts for ChatGPT, Claude, and Gemini, and exports to TXT, SRT, VTT, or Markdown.